Healthcare / Medical Care FacilitiesHKSE
$4.93
-0.22 (-4.27%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $122.1M · quality 63.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
31/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$6.5B
P/E
N/A
•EV/EBITDA
50.3x
↑ROE
-0.9%
↓Gross Margin
17.0%
↓Debt/Equity
0.36
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.7%
FCF CAGR
+33.2%
FCF margin
16.5%
FCF / Net income
-14.23x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.12B · net income $-13.0M · FCF $184.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.12B | $1.12B | $1.19B | $1.07B | $802.7M |
| Net Income | $-13.0M | $-13.0M | $-13.5M | $-26.4M | $-58.0M |
| EBITDA | $121.7M | $121.7M | $122.2M | $108.3M | $35.6M |
| EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Gross Margin | 17.0% | 17.0% | 17.5% | 16.6% | 9.9% |
| Operating Margin | 2.1% | 2.1% | 2.7% | 2.0% | -4.8% |
| Net Margin | -1.2% | -1.2% | -1.1% | -2.5% | -7.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.36 | 0.36 | 0.48 | 0.49 | 0.46 |
| Current Ratio | 1.69 | 1.69 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $184.4M | $184.4M | $122.1M | $74.6M | $78.0M |
| Returns | |||||
| ROE | -0.9% | -0.9% | -1.3% | -2.4% | -5.9% |
| Valuation | |||||
| EV/EBITDA | 50.32 | 50.32 | — | — | — |
| P/B | 4.07 | 4.07 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -5.8% | -5.8% | 10.9% | 33.6% | — |
| EPS Growth | 2.0% | 2.0% | 49.0% | 54.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-17.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → -0.01
Residual
-17.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.